Oryon Cell Therapies: Funding, Investors & Team (Oct 2026)
Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses, first focusing on Parkinson's disease.
Oryon Cell Therapies has raised $21.0M across 1 funding round on record, the most recent a Series A of $21.0M announced in Mar 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oryon Cell Therapies Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Oryon Cell Therapies Funding Rounds
Oryon Cell Therapies Founders and Leadership Team
Contact details for the Oryon Cell Therapies team: 1 has a LinkedIn profile.
Start 14-day free trial →Oryon Cell Therapies Funding Compared to Other Biotechnology Startups
Oryon Cell Therapies' latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Biotechnology Startups Like Oryon Cell Therapies
Companies Similar to Oryon Cell Therapies
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Oryon Cell Therapies Funding FAQs
What does Oryon Cell Therapies do?
Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses, first focusing on Parkinson's disease.
How much funding has Oryon Cell Therapies raised?
Oryon Cell Therapies has raised $21.0M across 1 round on record. The most recent is a Series A of $21.0M announced in Mar 2026.
When did Oryon Cell Therapies last raise funding?
Oryon Cell Therapies' most recent funding round on record is a Series A of $21.0M, announced in Mar 2026.
Who founded Oryon Cell Therapies?
FundedIQ lists Nikola Kojic (Founder) at Oryon Cell Therapies.
How many employees does Oryon Cell Therapies have?
Oryon Cell Therapies is in the 1-10 employee band.
How does Oryon Cell Therapies' funding compare to other Biotechnology startups?
Oryon Cell Therapies' latest round of $21.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Oryon Cell Therapies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oryon Cell Therapies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.